Download tools and resources for chemotherapy patients

After being diagnosed with cancer, many people begin searching for information and support to help them deal with this life-changing event.

These tools will help you define your risk of chemotherapy-induced nausea and vomiting (CINV). The resources available here will give you access to more information about CINV and online resources dedicated to cancer and cancer support.

ALOXI Patient Brochure: Gain an understanding of CINV and how ALOXI may help prevent it
ALOXI® Patient Brochure
Download this brochure to gain an understanding of CINV and how ALOXI may help prevent it
ALOXI® Patient Brochure in Spanish (En Español)
Download this Spanish-translated brochure to gain an understanding of CINV and how ALOXI may help prevent it
CINV Symptom Tracker: A downloadable and printable CINV symptom tracker to gauge the effects of chemotherapy
Track Your CINV Symptoms
Download and print this CINV symptom tracker so you can gauge how you are affected by your chemotherapy. Be sure to share it with your doctor or nurse

If you have questions about CINV or how ALOXI might help, ask your doctor or nurse. They are the best source for information about your cancer and treatment.

Indication in Adults

  • ALOXI® injection 0.25 mg/5 mL is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.

Indication in Pediatrics

  • ALOXI injection 20 mcg/kg (max 1.5 mg) is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.

Important Safety Information

  • ALOXI can cause allergic reactions that can be serious. Tell your doctor or nurse right away if you have any of these following symptoms of a serious allergic reaction: hives, swelling of the face, trouble breathing and chest pain

  • The most common side effects of ALOXI in adults are headache and constipation

  • Tell your doctor or nurse if you are taking other medications or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed

For more information about ALOXI, talk to your doctor or see full Prescribing Information.

ALOXI is available by prescription only.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

This site is intended for residents of the United States only. Any products discussed herein may have different product labeling in different countries.

This website contains information relating to various medical conditions and treatment. Such information is provided for educational purposes only and is not meant to be a substitute for the advice of a physician or other healthcare professionals. You should not use this information for diagnosing a health problem or disease. In order for you to make intelligent healthcare decisions, you should always consult with a physician or other healthcare provider for you, or your loved ones', personal medical needs. All quotes included in this website represent the individual experience of some doctors, some patients, and their caregivers. Individual responses to treatment may vary. Actual identities have been changed to protect individual privacy.

To report SUSPECTED ADVERSE REACTIONS, contact EISAI at 1-888-422-4743 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

ALOXI® is a registered trademark of Helsinn Healthcare SA, Switzerland, used under license.
Distributed by Eisai Inc. under license of Helsinn Healthcare SA, Switzerland. Marketed by Eisai Inc. and Helsinn Therapeutics (U.S.), Inc.
© 2016 Eisai Inc. All rights reserved. ALOX-US0149 07/16

Important Safety Information Expand

Indication in Adults

  • ALOXI® injection 0.25 mg/5 mL is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.

Indication in Pediatrics

  • ALOXI injection 20 mcg/kg (max 1.5 mg) is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.

Important Safety Information

  • ALOXI can cause allergic reactions that can be serious. Tell your doctor or nurse right away if you have any of these following symptoms of a serious allergic reaction: hives, swelling of the face, trouble breathing and chest pain

  • The most common side effects of ALOXI in adults are headache and constipation

  • Tell your doctor or nurse if you are taking other medications or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed

For more information about ALOXI, talk to your doctor or see full Prescribing Information.

ALOXI is available by prescription only.

You are now leaving ALOXI.com

Eisai Inc. does not review the information contained on the following website for content, accuracy, or completeness. Use of and access to the information is subject to the terms, limitations, and conditions set by the website producer. Eisai Inc. makes no claims about the accuracy or any other aspect of the information contained on this website, nor does Eisai Inc. endorse this website.

CANCEL CONTINUE

Healthcare professionals

This information is intended for US healthcare professionals. Click the "CONTINUE" button below to verify that you are a US healthcare professional, or the "CANCEL" button to return to the previous page.

CANCEL CONTINUE